M. K. Ramirez‐Fort, B. Meier‐Schiesser, K. Lachance, S. S. Mahase, C. D. Church, M. J. Niaz, . . . N. H. Bander. (2021). Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma. Wiley.
Chicago Style (17th ed.) CitationM. K. Ramirez‐Fort, et al. Folate Hydrolase‐1 (FOLH1) Is a Novel Target for Antibody‐based Brachytherapy in Merkel Cell Carcinoma. Wiley, 2021.
MLA (9th ed.) CitationM. K. Ramirez‐Fort, et al. Folate Hydrolase‐1 (FOLH1) Is a Novel Target for Antibody‐based Brachytherapy in Merkel Cell Carcinoma. Wiley, 2021.
Warning: These citations may not always be 100% accurate.